The RMH researchers receive more than $100,000 from TAC
21 September 2022
Researchers at the Royal Melbourne Hospital (RMH) have received $109,000 from the Transport Accident Commission (TAC) to look at improving outcomes for patients presenting with pelvic trauma.
The RMH and WEHI join forces to develop blood test to diagnose dementia
21 June 2022
The Royal Melbourne Hospital’s (RMH) Associate Professor Cherie Chiang and WEHI's Associate Professor Andrew Webb are developing an early diagnosis test for dementia at the Colonial Foundation Healthy Ageing Centre.
Severity of MS linked to distance from the equator
03 June 2022
A large international study has found that the severity of multiple sclerosis (MS) can vary depending on latitude, with those living furthest from the equator worse affected by the disease.
Study links goat’s milk skincare and new-onset severe food allergy
08 April 2022
As the first of its kind in Australia, a study looking at goat’s and sheep’s milk has shown a link between new-onset severe food allergy, including anaphylaxis to the use of goat’s milk containing skincare products in individuals with inflammatory skin conditions, such as eczema.
Global study hopes to find cure for HIV
04 April 2022
HIV infection is a chronic condition that remains a major global health problem, with an estimated 38 million people world-wide living with the disease.
New study paves the way for more effective COVID-19 research and treatment
07 February 2022
A Melbourne-led study, involving researchers from the Royal Melbourne Hospital (RMH), suggests that a primary tissue culture model is more effective at recreating the human experience of COVID-19, leading to more accurate treatments for the condition.
The RMH partners with Australian Centre for Accelerating Diabetes Innovations
18 January 2022
A national diabetes research centre initiative involving the Royal Melbourne Hospital has been funded through a significant Australian Government grant.
From idea to impact through the Innovation Acceleration Program
12 January 2022
The Royal Melbourne Hospital and University of Melbourne’s Innovation Acceleration Program (IAP) has awarded funding to three new projects.
Researchers look at nasal spray to treat respiratory infections
20 December 2021
A group of researchers from the Royal Melbourne Hospital and Peter MacCallum Cancer Centre are investigating a nasal spray option to prevent respiratory viral infections, such as COVID-19 and the flu.
Phase I study of two second generation COVID-19 variant vaccines
26 October 2021
The Doherty Institute, a joint venture between The University of Melbourne and the Royal Melbourne Hospital, has been funded through the National Health and Medical Research Council (NHMRC) by the Medical Research Future Fund to conduct a unique Phase I study of two second generation COVID-19 variant vaccines.